Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt 2.35
EW's Cash to Debt is ranked lower than
51% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: 2.56 vs. EW: 2.35 )
Ranked among companies with meaningful Cash to Debt only.
EW' s 10-Year Cash to Debt Range
Min: 0  Med: 0.89 Max: N/A
Current: 2.35
Equity to Asset 0.63
EW's Equity to Asset is ranked lower than
54% of the 282 Companies
in the Global Medical Devices industry.

( Industry Median: 0.66 vs. EW: 0.63 )
Ranked among companies with meaningful Equity to Asset only.
EW' s 10-Year Equity to Asset Range
Min: 0.37  Med: 0.59 Max: 0.74
Current: 0.63
0.37
0.74
Interest Coverage 71.70
EW's Interest Coverage is ranked lower than
61% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 10000.00 vs. EW: 71.70 )
Ranked among companies with meaningful Interest Coverage only.
EW' s 10-Year Interest Coverage Range
Min: 1.04  Med: 24.06 Max: 9999.99
Current: 71.7
1.04
9999.99
F-Score: 5
Z-Score: 10.49
M-Score: -2.10
WACC vs ROIC
5.51%
36.08%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 24.23
EW's Operating margin (%) is ranked higher than
99% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 3.12 vs. EW: 24.23 )
Ranked among companies with meaningful Operating margin (%) only.
EW' s 10-Year Operating margin (%) Range
Min: -29.23  Med: 16.39 Max: 53.09
Current: 24.23
-29.23
53.09
Net-margin (%) 18.08
EW's Net-margin (%) is ranked higher than
98% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 1.99 vs. EW: 18.08 )
Ranked among companies with meaningful Net-margin (%) only.
EW' s 10-Year Net-margin (%) Range
Min: -33.83  Med: 10.39 Max: 34.92
Current: 18.08
-33.83
34.92
ROE (%) 20.65
EW's ROE (%) is ranked higher than
98% of the 287 Companies
in the Global Medical Devices industry.

( Industry Median: 3.14 vs. EW: 20.65 )
Ranked among companies with meaningful ROE (%) only.
EW' s 10-Year ROE (%) Range
Min: -32.69  Med: 15.04 Max: 43.42
Current: 20.65
-32.69
43.42
ROA (%) 12.72
EW's ROA (%) is ranked higher than
97% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: -0.22 vs. EW: 12.72 )
Ranked among companies with meaningful ROA (%) only.
EW' s 10-Year ROA (%) Range
Min: -21.38  Med: 9.39 Max: 26.02
Current: 12.72
-21.38
26.02
ROC (Joel Greenblatt) (%) 68.69
EW's ROC (Joel Greenblatt) (%) is ranked higher than
98% of the 315 Companies
in the Global Medical Devices industry.

( Industry Median: 3.55 vs. EW: 68.69 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
EW' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -171.33  Med: 43.60 Max: 134.3
Current: 68.69
-171.33
134.3
Revenue Growth (3Y)(%) 15.00
EW's Revenue Growth (3Y)(%) is ranked higher than
84% of the 193 Companies
in the Global Medical Devices industry.

( Industry Median: 3.00 vs. EW: 15.00 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
EW' s 10-Year Revenue Growth (3Y)(%) Range
Min: 0  Med: 10.60 Max: 15
Current: 15
0
15
EBITDA Growth (3Y)(%) 57.70
EW's EBITDA Growth (3Y)(%) is ranked higher than
94% of the 170 Companies
in the Global Medical Devices industry.

( Industry Median: 2.10 vs. EW: 57.70 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
EW' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0  Med: 16.00 Max: 57.7
Current: 57.7
0
57.7
EPS Growth (3Y)(%) 55.70
EW's EPS Growth (3Y)(%) is ranked higher than
92% of the 171 Companies
in the Global Medical Devices industry.

( Industry Median: -0.40 vs. EW: 55.70 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
EW' s 10-Year EPS Growth (3Y)(%) Range
Min: 0  Med: 21.05 Max: 348.1
Current: 55.7
0
348.1
» EW's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2014

EW Guru Trades in Q3 2014

RS Investment Management 62,460 sh (New)
Steven Cohen 206,300 sh (New)
Paul Tudor Jones 10,112 sh (+102.24%)
Jim Simons 20,900 sh (+8.29%)
Joel Greenblatt 272,994 sh (+5.37%)
PRIMECAP Management 280,000 sh (unchged)
Pioneer Investments 195,380 sh (unchged)
Jeremy Grantham 150,665 sh (-10.02%)
Vanguard Health Care Fund 4,207,470 sh (-14.48%)
Ron Baron 836,867 sh (-22.73%)
» More
Q4 2014

EW Guru Trades in Q4 2014

Jim Simons 484,500 sh (+2218.18%)
PRIMECAP Management 280,000 sh (unchged)
Steven Cohen Sold Out
RS Investment Management 60,839 sh (-2.60%)
Joel Greenblatt 247,876 sh (-9.20%)
Pioneer Investments 175,690 sh (-10.08%)
Jeremy Grantham 127,469 sh (-15.40%)
Vanguard Health Care Fund 3,402,670 sh (-19.13%)
Ron Baron 576,836 sh (-31.07%)
Paul Tudor Jones 6,196 sh (-38.73%)
» More
Q1 2015

EW Guru Trades in Q1 2015

Lee Ainslie 1,960 sh (New)
Steven Cohen 239,400 sh (New)
Paul Tudor Jones 106,095 sh (+1612.31%)
Jim Simons 668,400 sh (+37.96%)
Jeremy Grantham 134,069 sh (+5.18%)
Vanguard Health Care Fund 3,402,670 sh (unchged)
PRIMECAP Management 280,000 sh (unchged)
Ron Baron 570,988 sh (-1.01%)
RS Investment Management 59,621 sh (-2.00%)
Joel Greenblatt 241,467 sh (-2.59%)
Pioneer Investments 162,473 sh (-7.52%)
» More
Q2 2015

EW Guru Trades in Q2 2015

John Hussman 25,000 sh (New)
Vanguard Health Care Fund 3,402,670 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with EW

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 38.02
EW's P/E(ttm) is ranked higher than
71% of the 156 Companies
in the Global Medical Devices industry.

( Industry Median: 28.40 vs. EW: 38.02 )
Ranked among companies with meaningful P/E(ttm) only.
EW' s 10-Year P/E(ttm) Range
Min: 11.18  Med: 27.30 Max: 50.48
Current: 38.02
11.18
50.48
Forward P/E 32.57
EW's Forward P/E is ranked lower than
74% of the 96 Companies
in the Global Medical Devices industry.

( Industry Median: 23.26 vs. EW: 32.57 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 38.20
EW's PE(NRI) is ranked higher than
71% of the 154 Companies
in the Global Medical Devices industry.

( Industry Median: 28.30 vs. EW: 38.20 )
Ranked among companies with meaningful PE(NRI) only.
EW' s 10-Year PE(NRI) Range
Min: 11.18  Med: 27.51 Max: 50.57
Current: 38.2
11.18
50.57
P/B 7.14
EW's P/B is ranked lower than
85% of the 287 Companies
in the Global Medical Devices industry.

( Industry Median: 3.11 vs. EW: 7.14 )
Ranked among companies with meaningful P/B only.
EW' s 10-Year P/B Range
Min: 2.91  Med: 4.42 Max: 8.46
Current: 7.14
2.91
8.46
P/S 6.86
EW's P/S is ranked lower than
76% of the 290 Companies
in the Global Medical Devices industry.

( Industry Median: 3.15 vs. EW: 6.86 )
Ranked among companies with meaningful P/S only.
EW' s 10-Year P/S Range
Min: 2.21  Med: 3.75 Max: 7.38
Current: 6.86
2.21
7.38
PFCF 67.71
EW's PFCF is ranked higher than
74% of the 115 Companies
in the Global Medical Devices industry.

( Industry Median: 30.88 vs. EW: 67.71 )
Ranked among companies with meaningful PFCF only.
EW' s 10-Year PFCF Range
Min: 7.82  Med: 26.46 Max: 534.25
Current: 67.71
7.82
534.25
POCF 48.07
EW's POCF is ranked higher than
64% of the 149 Companies
in the Global Medical Devices industry.

( Industry Median: 21.63 vs. EW: 48.07 )
Ranked among companies with meaningful POCF only.
EW' s 10-Year POCF Range
Min: 7.33  Med: 18.66 Max: 48.93
Current: 48.07
7.33
48.93
EV-to-EBIT 26.65
EW's EV-to-EBIT is ranked higher than
77% of the 162 Companies
in the Global Medical Devices industry.

( Industry Median: 21.84 vs. EW: 26.65 )
Ranked among companies with meaningful EV-to-EBIT only.
EW' s 10-Year EV-to-EBIT Range
Min: 6.4  Med: 18.20 Max: 69.5
Current: 26.65
6.4
69.5
PEG 1.36
EW's PEG is ranked higher than
93% of the 55 Companies
in the Global Medical Devices industry.

( Industry Median: 3.42 vs. EW: 1.36 )
Ranked among companies with meaningful PEG only.
EW' s 10-Year PEG Range
Min: 0.41  Med: 1.41 Max: 3.5
Current: 1.36
0.41
3.5
Shiller P/E 43.60
EW's Shiller P/E is ranked lower than
67% of the 94 Companies
in the Global Medical Devices industry.

( Industry Median: 30.75 vs. EW: 43.60 )
Ranked among companies with meaningful Shiller P/E only.
EW' s 10-Year Shiller P/E Range
Min: 25.2  Med: 43.03 Max: 69.38
Current: 43.6
25.2
69.38
Current Ratio 5.16
EW's Current Ratio is ranked higher than
78% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 2.71 vs. EW: 5.16 )
Ranked among companies with meaningful Current Ratio only.
EW' s 10-Year Current Ratio Range
Min: 0.89  Med: 2.59 Max: 5.56
Current: 5.16
0.89
5.56
Quick Ratio 4.46
EW's Quick Ratio is ranked higher than
79% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 2.03 vs. EW: 4.46 )
Ranked among companies with meaningful Quick Ratio only.
EW' s 10-Year Quick Ratio Range
Min: 0.49  Med: 1.98 Max: 4.83
Current: 4.46
0.49
4.83
Days Inventory 179.17
EW's Days Inventory is ranked lower than
68% of the 281 Companies
in the Global Medical Devices industry.

( Industry Median: 131.01 vs. EW: 179.17 )
Ranked among companies with meaningful Days Inventory only.
EW' s 10-Year Days Inventory Range
Min: 97.78  Med: 133.65 Max: 208.39
Current: 179.17
97.78
208.39
Days Sales Outstanding 52.67
EW's Days Sales Outstanding is ranked higher than
74% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 68.21 vs. EW: 52.67 )
Ranked among companies with meaningful Days Sales Outstanding only.
EW' s 10-Year Days Sales Outstanding Range
Min: 38.74  Med: 47.18 Max: 69.95
Current: 52.67
38.74
69.95

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 8.66
EW's Price/Tangible Book is ranked lower than
74% of the 261 Companies
in the Global Medical Devices industry.

( Industry Median: 4.35 vs. EW: 8.66 )
Ranked among companies with meaningful Price/Tangible Book only.
EW' s 10-Year Price/Tangible Book Range
Min: 5.57  Med: 9.13 Max: 188.29
Current: 8.66
5.57
188.29
Price/DCF (Earnings Based) 1.34
EW's Price/DCF (Earnings Based) is ranked higher than
87% of the 16 Companies
in the Global Medical Devices industry.

( Industry Median: 1.69 vs. EW: 1.34 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Earnings Yield (Greenblatt) (%) 3.71
EW's Earnings Yield (Greenblatt) (%) is ranked higher than
88% of the 308 Companies
in the Global Medical Devices industry.

( Industry Median: 0.60 vs. EW: 3.71 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
EW' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 1.4  Med: 5.50 Max: 15.6
Current: 3.71
1.4
15.6
Forward Rate of Return (Yacktman) (%) 38.99
EW's Forward Rate of Return (Yacktman) (%) is ranked higher than
94% of the 99 Companies
in the Global Medical Devices industry.

( Industry Median: 4.14 vs. EW: 38.99 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
EW' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: 3.2  Med: 18.00 Max: 40.6
Current: 38.99
3.2
40.6

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:EWL.Germany,
Edwards Lifesciences Corp was incorporated in Delaware on September 10, 1999. The Company is the manufacturer of heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. It is also a global leader in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. It conducts operations worldwide and are managed in the following geographical regions: United States, Europe, Japan and Rest of World. The products and technologies provided by the Company to treat advanced cardiovascular disease or critically ill patients are categorized into the following main areas: Surgical Heart Valve Therapy, Transcatheter Heart Valves, and Critical Care. The Company's Surgical Heart Valve Therapy portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The portfolio also includes a diverse line of cardiac surgery systems used during minimally invasive surgical procedures, and cannulae, embolic protection devices and other products used during cardiopulmonary bypass. The Company's Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. In the Critical Care portfolio, Edwards Lifesciences' products include pulmonary artery catheters, disposable pressure transducers and advanced monitoring systems. The portfolio also includes a line of balloon catheter-based vascular products, surgical clips and inserts. The Company competes with many companies, including divisions of companies much larger than it and smaller companies that compete in specific product lines or certain geographies. The Company's Surgical Heart Valve Therapy and Transcatheter Heart Valve products are manufactured in California and Utah in the United States, Switzerland, and Singapore. Critical Care products are manufactured primarily in its facilities located in Puerto Rico and the Dominican Republic. The Company's products and technologies are subject to regulation by numerous domestic and foreign government agencies, including the FDA, and various laws and regulations governing the development, testing, manufacturing, labeling, marketing and distribution of its products and technologies.
» More Articles for EW

Headlines

Articles On GuruFocus.com
East West Petroleum Ends Fiscal Year 2015 With Record Revenues and Strong Financial Position Jul 30 2015 
COE May 28 2015 
The Problem with Mechanical Investment Strategies and How You Can Find Your Own Ideas May 27 2015 
Vanguard Health Care Fund's Undervalued Stocks Apr 03 2015 
Fairly Valued Long-Term Performer – Edwards Lifesciences Mar 23 2015 
East West Petroleum to Renew Normal Course Issuer Bid Jan 27 2015 
Edwards Lifesciences a Gold Standard in the Market Dec 16 2014 
East West Petroleum Provides Operational Update Dec 16 2014 
Edwards Lifesciences Invests $50 Million in New Heart Failure Technology Dec 10 2014 
East West Petroleum Announces Drilling of Cheal-E6 Well in New Zealand Nov 26 2014 

More From Other Websites
Edwards Announces Board Change Jul 30 2015
EDWARDS LIFESCIENCES CORP Files SEC form 8-K, Change in Directors or Principal Officers Jul 30 2015
Edwards Announces Board Change Jul 30 2015
St. Jude Buying Thoratec Could Resusitate Medtech M&As Jul 30 2015
EDWARDS LIFESCIENCES CORP Files SEC form 10-Q, Quarterly Report Jul 29 2015
Edwards Lifesciences Beats Earnings, Sales; EPS View Up - Analyst Blog Jul 29 2015
Edwards Lifesciences (EW) Earnings Report: Q2 2015 Conference Call Transcript Jul 29 2015
Edited Transcript of EW earnings conference call or presentation 28-Jul-15 9:00pm GMT Jul 29 2015
Edwards Keeps Earnings Streak Alive With Q2 Beat Jul 28 2015
Edwards Lifesciences Corp Earnings Call scheduled for 5:00 pm ET today Jul 28 2015
Edwards Lifesciences Reports Second Quarter Results Jul 28 2015
Edwards Lifesciences raises outlook on strong valve sales Jul 28 2015
Edwards Lifesciences beats Street 2Q forecasts Jul 28 2015
Edwards Lifesciences beats Street 2Q forecasts Jul 28 2015
EDWARDS LIFESCIENCES CORP Files SEC form 8-K, Results of Operations and Financial Condition,... Jul 28 2015
Edwards Lifesciences Reports Second Quarter Results Jul 28 2015
5 Health Care Stocks to Trade for Gains -- Must-See Charts Jul 28 2015
Q2 2015 Edwards Lifesciences Corp Earnings Release - After Market Close Jul 28 2015
Meet 5 IBD 50 Stocks Reporting Earnings This Week Jul 25 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK